These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
227 related items for PubMed ID: 17195068
1. A limited sampling strategy to estimate individual pharmacokinetic parameters of methotrexate in children with acute lymphoblastic leukemia. Plard C, Bressolle F, Fakhoury M, Zhang D, Yacouben K, Rieutord A, Jacqz-Aigrain E. Cancer Chemother Pharmacol; 2007 Sep; 60(4):609-20. PubMed ID: 17195068 [Abstract] [Full Text] [Related]
2. Population pharmacokinetic study of methotrexate in patients with lymphoid malignancy. Faltaos DW, Hulot JS, Urien S, Morel V, Kaloshi G, Fernandez C, Xuan kH, Leblond V, Lechat P. Cancer Chemother Pharmacol; 2006 Nov; 58(5):626-33. PubMed ID: 16528531 [Abstract] [Full Text] [Related]
3. A limited sampling strategy for estimating individual pharmacokinetic parameters of coagulation factor VIII in patients with hemophilia A. Bolon-Larger M, Chamouard V, Bressolle F, Boulieu R. Ther Drug Monit; 2007 Feb; 29(1):20-6. PubMed ID: 17304146 [Abstract] [Full Text] [Related]
4. High dose methotrexate population pharmacokinetics and Bayesian estimation in patients with lymphoid malignancy. Min Y, Qiang F, Peng L, Zhu Z. Biopharm Drug Dispos; 2009 Nov; 30(8):437-47. PubMed ID: 19746402 [Abstract] [Full Text] [Related]
5. [Pharmacokinetic monitoring of 24-hour infusion of methotrexate in an adult population with non-Hodgkin lymphoma]. Fernández Megía MJ, Alós Almiñana M, Esquer Borrás J. Farm Hosp; 2004 Nov; 28(6):433-9. PubMed ID: 15628946 [Abstract] [Full Text] [Related]
6. Population pharmacokinetics of prednisolone in children with acute lymphoblastic leukemia. Petersen KB, Jusko WJ, Rasmussen M, Schmiegelow K. Cancer Chemother Pharmacol; 2003 Jun; 51(6):465-73. PubMed ID: 12698270 [Abstract] [Full Text] [Related]
8. Population pharmacokinetics of high-dose methotrexate in children with acute lymphoblastic leukaemia. Aumente D, Buelga DS, Lukas JC, Gomez P, Torres A, García MJ. Clin Pharmacokinet; 2006 May; 45(12):1227-38. PubMed ID: 17112298 [Abstract] [Full Text] [Related]
9. Prediction of methotrexate elimination after high dose infusion in children with acute lymphoblastic leukaemia using a population pharmacokinetic approach. Odoul F, Le Guellec C, Lamagnère JP, Breilh D, Saux MC, Paintaud G, Autret-Leca E. Fundam Clin Pharmacol; 1999 May; 13(5):595-604. PubMed ID: 10520733 [Abstract] [Full Text] [Related]
10. [l-folinic acid versus racemic folinic acid in the treatment of leukemia in children with high dose of methotrexate]. Etienne MC, Thyss A, Bertrand Y, Rubie H, Milano G. Bull Cancer; 1993 Apr; 80(4):357-63. PubMed ID: 8173189 [Abstract] [Full Text] [Related]
11. [Studies of methotrexate pharmacokinetics in children with neoplasms of the hematopoietic system after administration of different doses of the drug]. Wysocki M, Krzyzanowski M, Ozyński T, Pilecki O, Balcar-Boroń A, Szadujkis-Szadurski L. Acta Haematol Pol; 1992 Apr; 23(3):179-83. PubMed ID: 1492542 [Abstract] [Full Text] [Related]
12. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis. Monjanel-Mouterde S, Lafforgue P, Blanc A, Catalin J, Aquaviva PC, Durand A. J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756 [Abstract] [Full Text] [Related]
13. Modeling plasma and saliva topotecan concentration time course using a population approach. Boucaud M, Pinguet F, Culine S, Poujol S, Astre C, Gomeni R, Bressolle F. Oncol Res; 2003 Jul; 13(4):211-9. PubMed ID: 12659422 [Abstract] [Full Text] [Related]
14. Population pharmacokinetics of high-dose methotrexate after intravenous administration in pediatric patients with osteosarcoma. Colom H, Farré R, Soy D, Peraire C, Cendros JM, Pardo N, Torrent M, Domenech J, Mangues MA. Ther Drug Monit; 2009 Feb; 31(1):76-85. PubMed ID: 19077931 [Abstract] [Full Text] [Related]
15. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance. Joannon P, Oviedo I, Campbell M, Tordecilla J. Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885 [Abstract] [Full Text] [Related]
16. Pharmacokinetics of continuous infusion of methotrexate and teniposide in pediatric cancer patients. Rodman JH, Sunderland M, Kavanagh RL, Ochs J, Yalowich J, Evans WE, Rivera GK. Cancer Res; 1990 Jul 15; 50(14):4267-71. PubMed ID: 2194652 [Abstract] [Full Text] [Related]
17. Influence of biological variables upon pharmacokinetic parameters of intramuscular methotrexate in rheumatoid arthritis. Debord J, Carpentier N, Sabot C, Bertin P, Marquet P, Treves R, Merle L, Lachâtre G. Int J Clin Pharmacol Ther; 1998 Apr 15; 36(4):227-30. PubMed ID: 9587050 [Abstract] [Full Text] [Related]
18. Population pharmacokinetic study of methotrexate in children with acute lymphoblastic leukemia. Zhang C, Zhai S, Yang L, Wu H, Zhang J, Ke X. Int J Clin Pharmacol Ther; 2010 Jan 15; 48(1):11-21. PubMed ID: 20040335 [Abstract] [Full Text] [Related]
19. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia. Kearns CM, Blakley RL, Santana VM, Crom WR. Cancer Res; 1994 Mar 01; 54(5):1235-9. PubMed ID: 7906999 [Abstract] [Full Text] [Related]
20. Renal function and methotrexate clearance in children with newly diagnosed leukemia. Murry DJ, Synold TW, Pui CH, Rodman JH. Pharmacotherapy; 1995 Mar 01; 15(2):144-9. PubMed ID: 7624260 [Abstract] [Full Text] [Related] Page: [Next] [New Search]